147 related articles for article (PubMed ID: 9642872)
1. [Campylobacter jejuni colitis and Guillain-Barre syndrome].
Fujimoto S
Fukuoka Igaku Zasshi; 1998 May; 89(5):127-32. PubMed ID: 9642872
[No Abstract] [Full Text] [Related]
2. Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome.
Yuki N
J Infect Dis; 1997 Dec; 176 Suppl 2():S150-3. PubMed ID: 9396700
[TBL] [Abstract][Full Text] [Related]
3. [Campylobacter jejuni enteritis and Guillain-Barré syndrome].
Yuki N
Rinsho Byori; 1999 Aug; 47(8):713-8. PubMed ID: 10511801
[TBL] [Abstract][Full Text] [Related]
4. [Campylobacter jejuni enteritis and Guillain-Barré syndrome].
Yuki N
Rinsho Shinkeigaku; 1999 Jan; 39(1):17-8. PubMed ID: 10377788
[TBL] [Abstract][Full Text] [Related]
5. [Axonal Guillain-Barré syndrome associated with anti-GalNAc-GD1a antibody subsequent to Campylobacter jejuni (PEN 43) enteritis].
Ihara Y; Saito K; Yoshimoto S; Hayabara T; Yuki N
Rinsho Shinkeigaku; 1995 Aug; 35(8):901-3. PubMed ID: 8665735
[TBL] [Abstract][Full Text] [Related]
6. Association of Campylobacter jejuni serotype with antiganglioside antibody in Guillain-Barré syndrome and Fisher's syndrome.
Yuki N; Takahashi M; Tagawa Y; Kashiwase K; Tadokoro K; Saito K
Ann Neurol; 1997 Jul; 42(1):28-33. PubMed ID: 9225682
[TBL] [Abstract][Full Text] [Related]
7. Guillain-Barre syndrome and Campylobacter jejuni infection. A study on the etiological characteristics of Guillain-Barre syndrome in China.
Yuan JM; Tang J; Chen QT; Xiao L; Hao HJ; Jia ZD; Huang QH; Liu XZ
Chin Med J (Engl); 1993 Nov; 106(11):845-7. PubMed ID: 8143497
[TBL] [Abstract][Full Text] [Related]
8. [Polyradiculoneuritis and Campylobacter jejuni: clinical and physiopathological aspects].
Diagana M; Khalil M; Preux PM; Dumas M; Jauberteau MO
Med Trop (Mars); 2003; 63(1):68-74. PubMed ID: 12891754
[TBL] [Abstract][Full Text] [Related]
9. [A case of Guillain-Barré syndrome after Campylobacter jejuni enterocolitis: anti-ganglioside antibody levels with or without Guillain-Barré syndrome].
Watanabe H; Shindo K; Nakamura Y; Nagamatsu M; Shiozawa Z; Kusunoki S
Rinsho Shinkeigaku; 2001 Sep; 41(9):625-7. PubMed ID: 11968750
[TBL] [Abstract][Full Text] [Related]
10. Lipopolysaccharides in the development of the Guillain-Barré syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies.
Prendergast MM; Moran AP
J Endotoxin Res; 2000; 6(5):341-59. PubMed ID: 11521055
[TBL] [Abstract][Full Text] [Related]
11. [Advances in the research on the pathogenic role of Campylobacter jejuni in Guillain-Barre syndrome].
Tang J; Yuan JM
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Dec; 25(6):375-7. PubMed ID: 1305004
[No Abstract] [Full Text] [Related]
12. Campylobacter infections, Guillain-Barré syndrome, and parenteral gangliosides.
Callegaro L; Jack DB; Samson JC
Lancet; 1991 Mar; 337(8744):789. PubMed ID: 1672406
[No Abstract] [Full Text] [Related]
13. Recognition characteristics of monoclonal antibodies that are cross-reactive with gangliosides and lipooligosaccharide from Campylobacter jejuni strains associated with Guillain-Barré and Fisher syndromes.
Houliston RS; Yuki N; Hirama T; Khieu NH; Brisson JR; Gilbert M; Jarrell HC
Biochemistry; 2007 Jan; 46(1):36-44. PubMed ID: 17198373
[TBL] [Abstract][Full Text] [Related]
14. [Etiological mechanism and treatment of Guillain-Barre syndrome-- Campylobacter jejuni enteritis and the development of anti-ganglioside antibody preceding the syndrome].
Yuki N
Nihon Naika Gakkai Zasshi; 1998 Apr; 87(4):612-6. PubMed ID: 9627467
[No Abstract] [Full Text] [Related]
15. Anti-ganglioside antibodies in patients with Guillain-Barré syndrome and Campylobacter jejuni infection.
Rees JH; Gregson NA; Hughes RA
J Infect Dis; 1995 Aug; 172(2):605-6. PubMed ID: 7622918
[No Abstract] [Full Text] [Related]
16. [Campylobacter jejuni and autoimmune-mediated neurologic diseases: pathogenesis of Guillain-Barré syndrome and Fisher's syndrome].
Yuki N
Nihon Saikingaku Zasshi; 1995 Oct; 50(4):991-1003. PubMed ID: 8544349
[No Abstract] [Full Text] [Related]
17. Serotype of Campylobacter jejuni, HLA, and the Guillain-Barré syndrome.
Yuki N; Sato S; Fujimoto S; Yamada S; Tsujino Y; Kinoshita A; Itoh T
Muscle Nerve; 1992 Aug; 15(8):968-9. PubMed ID: 1495517
[No Abstract] [Full Text] [Related]
18. The Guillain-Barré syndrome at 75: the Campylobacter connection.
Griffin JW; Ho TW
Ann Neurol; 1993 Aug; 34(2):125-7. PubMed ID: 8338335
[No Abstract] [Full Text] [Related]
19. Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome.
Koga M; Takahashi M; Masuda M; Hirata K; Yuki N
Neurology; 2005 Nov; 65(9):1376-81. PubMed ID: 16162859
[TBL] [Abstract][Full Text] [Related]
20. Ganglioside GM1 mimicry in Campylobacter strains from sporadic infections in the United States.
Nachamkin I; Ung H; Moran AP; Yoo D; Prendergast MM; Nicholson MA; Sheikh K; Ho T; Asbury AK; McKhann GM; Griffin JW
J Infect Dis; 1999 May; 179(5):1183-9. PubMed ID: 10191221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
